JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 21 No. 3 279-281
© 1980 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, A. G.
Right arrow Articles by Davis, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, A. G.
Right arrow Articles by Davis, M. A.

A Survey of Reducing Agents for the Synthesis of Tetraphenylarsonium Oxotechnetiumbis(ethanedithiolate) from [99Tc] Pertechnetate in Aqueous Solution

Alun G. Jones, Chris Orvig, Harvey S. Trop, Alan Davison and Michael A. Davis

Harvard Medical School and Peter Bent Brigham Hospital, Boston
Massachusetts Institute of Technology, Cambridge, Massachusetts

Correspondence: For reprints contact: Alun G. Jones, PhD, Harvard Medical School, 50 Binney St., Boston, MA 02115.

ABSTRACT

We have studied the effectiveness of various reducing agents in the production of the well-characterized complex [99TcO(SCH2CH2S)2] from pertechnetate and ethanedithiol in aqueous solution. The reductants tested included sodium dithionite, hypophosphorous acid, formamidine sulfinic acid, dithiothreitol, hydrazine, and hydroxylamine. Of these, only sodium dithionite in the pH range 11-13 was found to give quantitative yields of the required technetium complex.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1980 by the Society of Nuclear Medicine.